Skip to main content
Get the latest market insights and industry trends on Regulatory, Data, Pharmacy and Health   Register for the spring Regulatory Roundtable Discussion   Webinar on Demand for MRIoA's High-Cost Specialty Drug Review Webinar

Medical Review Institute of America (MRIoA) Sponsors AHIP 2024

Medical Review Institute of America (MRIoA) is once again a proud to sponsor AHIP 2024. We look forward to engaging with industry leaders like yourself as we work together to reimagining the future of health care. Be sure to stop by booth #1627 where we can delve into the pressing issues affecting your organization today and how MRIoA can help alleviate those burdens.

MRIoA has devoted the last 40+ years to transforming health care with our innovative solutions. Our Clinical Solutions Platform™ takes the data we receive from our Clinical Review Services coupled with MRIoA Insights™ and creates a patient-centered approach ensuring patients receive the appropriate care at the right time in the right place.

  • High-Cost Specialty Drug Reviews™ – Our specialty drug review solution uses evidence-based guidelines for treating medical conditions and offers lower-cost drug alternatives when they are available. One client realized a 17:1 ROI* with this program.
  • PA Optimization Platform™ – Optimize your prior authorization (PA) program with our cutting-edge platform. This program delivers $7M savings annually per 100K lives, or a 7:1 ROI.
  • MyCareChoices™ – Proactive Second Opinion – This innovative service delivers rapid and reliable proactive second opinions and offers conservative treatment options from world-class medical specialists. Your organization can realize $800K in savings for every 100K lives.
We are MRIoA:
  • Providing services to more than 900+ clients across 50% of all third-party administrators, 70% of Blues plans, 8 of the 10 largest health plans and 6 of the largest PBMs
  • Monitoring regulatory requirements across multiple states to ensure our clients meet the compliance standards
  • Delivering technology enabled review services, increasing patient satisfaction and reducing unnecessary care
  • Providing benchmarking analytics and empowering employees by offering them alternative choices through patient-focused telehealth 2nd opinion services
  • Industry-leading <4 hours TAT on over 81% of qualified reviews while maintaining the quality you expect
  • Over 230+ internal clinical resources and 700+ physician reviewers across 150+ specialties
  • Licensure in all 50 states

Stop by our booth #1627 on Tuesday afternoon, June 11th from 6:15 pm to 7:15 pm and enjoy some wine in a MRIoA keepsake glass. Engage with Marise Condon, Vice President of Sales for Strategic Accounts, and Jamie Suchy, Vice President of Sales and Team Lead for Strategic Accounts, during AHIP 2024 to learn more of what MRIoA can do for your organization. We look forward to seeing you in person at our booth #1627. In the meantime, to learn more about MRIoA contact us at www.mrioa.com, 800-654-2422.

*Results as of 3/30/24

About Medical Review Institute of America, LLC, (MRIoA). Founded in 1983, Medical Review Institute of America, LLC (MRIoA) is the top medical review company in the United States. With the largest, most extensive review network, industry-leading turnaround times (TATs), and UR licensing in all states that require it, our professionalism, enthusiasm and collaborative approach are transforming clinical care delivery nationwide. MRIoA is a technology-enabled provider of clinical insights to payers and patients through analytics and evidence-based clinical opinions derived from independent specialty reviews and virtual 2nd opinion solutions that empower better decision-making.

Bre Legler
MRIoA
bre.legler@mrioa.com
800-654-2422 ext:6538